Grant ID

01T-049

Illness

Schizophrenia

Primary Drug/Intervention

Chromium Picolinate

Primary Dosage

400 mg

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Cowen

Sample Size

112

Duration of Study Period for Each Subject

3 months

Outcome Measurements

PANSS, BPRS, HAM-D, CGI, EPS

Results

Chromium was well tolerated but did not produce any benefit over placebo for psychiatric symptoms or body weight.

Publication

Hockney RA, Montgomery P, Williams C, Geddes JR, Cowen PJ. Lack of effect of chromium supplementation on mental state and body weight in people with schizophrenia. J Clin Psychopharmacol. 2006 Oct;26(5):544-5.

Link

http://www.ncbi.nlm.nih.gov/pubmed/16974208

PI Name

Philip Cowen

Degree

MD

Center

Neurosciences Building, Department of Psychiatry

Institution

University of Oxford, Warneford Hospital

Address

City or Town

Oxford

State or Province

N/A

Zip or Postal Code

OX3 7JX

Country

United Kingdom

Email Address

phil.cowen@psych.ox.ac.uk